Nombre del producto:1-Bromo-4-chloroimidazo[1,2-a]quinoxaline

IUPAC Name:1-bromo-4-chloroimidazo[1,2-a]quinoxaline

CAS:1254196-52-5
Fórmula molecular:C10H5BrClN3
Pureza:95%
Número de catálogo:CM221304
Peso molecular:282.53

Unidad de embalaje Stock disponible Precio($) Cantidad
CM221304-1g 1-2 Weeks ƙǕȁ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :1254196-52-5
Fórmula molecular:C10H5BrClN3
Punto de fusión:-
Código de sonrisas:ClC1=NC2=C(N3C1=NC=C3Br)C=CC=C2
Densidad:
Número de catálogo:CM221304
Peso molecular:282.53
Punto de ebullición:
Nº Mdl:MFCD18711463
Almacenamiento:

Category Infos

Quinoxalines
Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.
Imidazopyrazines
In addition to the nitrogen-based heterocycles presented so far, a number of others nitrogen-based scaffolds have also been reported as promising agents for GBM treatment, including pyrazolo-triazole, imidazotetrazine, piperidine, purine, imidazopyrazine, pyrazole, triazole among others.

Related Products